Ecolab Inc.

Ecolab Inc. is an American provider of water treatment, hygiene, cleaning, and infection prevention products and services, serving more than 40 industries across 170 countries with roughly 48,000 employees and $16.1 billion in revenue in fiscal 2025. The company's reach is broad but its model is simple: it sells consumable chemicals, dispensing equipment, and ongoing service — often on multi-year contracts where the chemistry itself is a small fraction of the customer's operating cost but a large determinant of uptime, safety, and quality. That asymmetry is the foundation of Ecolab's pricing power, its 33-year dividend-increase streak, and the 18% operating margin it posted in 2025.

This is a story about a 103-year-old industrial franchise funding an improbable second act. In December 2025, Ecolab closed the $1.6 billion acquisition of Ovivo's electronics division, adding ultrapure water technology for semiconductor manufacturing. In March 2026, it announced a $4.75 billion deal for CoolIT Systems, a pure-play direct-to-chip liquid cooling company whose hardware sits inside seven of the world's ten largest supercomputers. Together, these deals reposition roughly a fifth of Ecolab's portfolio toward AI infrastructure — chip fabrication and data center cooling — at a combined enterprise value approaching $6.4 billion. The file turns on a single question: whether Ecolab can turn data center cooling into a durable moat, or whether it has bought a fast-growing but ultimately contestable hardware business at the top of the AI investment cycle.

The core business remains formidable. Global Water, Institutional & Specialty, Pest Elimination, and Life Sciences generated $2.9 billion in adjusted operating income in 2025, up 13% organically. The "One Ecolab" restructuring program has raised its savings target twice and now aims for $325 million in annual run-rate savings by 2027, providing a visible path to 20% operating margins. But the CoolIT deal adds roughly $4.75 billion in debt to a balance sheet that carried $8.2 billion at year-end, and the acquisition's 29x near-term EBITDA multiple leaves little room for integration missteps or competitive inroads. What follows is an examination of the franchise, the transformation, the risks, and the price.